Life sciences software & AI news

Showing 1000+ results

Sep 17, 2026

MindMaze Therapeutics Announces MindMotion Lite to Expand Home-Based Neurorehabilitation

Expected by year-end 2026, the new solution brings the full range of MindMotion neurotherapeutic activities to a tablet-based format designed for easier deployment at homeGENEVA, Sept. 17, 2026 /PRNewswire/ -- MindMaze Therapeutics (SIX: MMTX), a global leader in scalable precision neurotherapeutics, today announced the launch of MindMotion Lite by the end of 2026. Purpose-built for use in the home, the new solution broadens access to intensive neurorehabilitation and represents a key inflection

Sep 17, 2026

Press release

Cumulus Neuroscience Presents Data at the ISCTM 2026 Autumn Conference

Interim data show high adherence and usability for remote, multimodal brain monitoring in borderline personality disorder and therapy-resistant depression, and a two-minute digital cognitive task performing comparably to clinical benchmarks for Alzheimer's trial pre-enrichment.BELFAST, Northern Ireland, Sept. 16, 2026 /PRNewswire/ -- First Published: 16 September, 2026Cumulus Neuroscience presented three posters at the International Society for CNS Clinical Trials and Methodology (ISCTM) Autumn

Sep 17, 2026

Press release

Ginkgo Datapoints Announces Partnership with TuneLab to Close the Gap between AI Models and Lab Data

Integration puts Ginkgo’s biological data generation services at the heart of the industry’s most prominent AI-driven drug discovery networkBOSTON--(BUSINESS WIRE)--Ginkgo Bioworks (NYSE: DNA) today announced that its Ginkgo Datapoints offering has entered into a new agreement with Lilly TuneLab, a collaborative AI/ML drug discovery platform created by Eli Lilly and Company (Lilly). TuneLab supports biotech innovation by enabling participating companies to access AI/ML drug discovery models trai

Sep 17, 2026

Press release

Mission Bio Launches Tapestri® Triomics for Simultaneous DNA, RNA, and Protein Analysis at Single-Cell Resolution

New Tapestri® capability connects genotype, gene expression, and phenotype in the same cell, giving researchers a direct view of how genetic alterations shape cellular behavior.SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Mission Bio, a leader in single-cell multi-omics, today announced Tapestri® Triomics, a new expansion of the Tapestri Platform that simultaneously analyzes DNA, RNA, and protein in the same cell. By connecting genotype, gene expression, and phenotype at single-cell resolution,

Sep 17, 2026

Press release

Cognita Imaging Receives $1.29 Million FDA Contract to Test New Approach to Evaluating Generative AI in Radiology

Research will test whether multiple language models can work as a jury to assess AI-generated reports across approximately 1 million patient exams, with radiologists reviewing clinically important discrepanciesNASHVILLE, Tenn. & PALO ALTO, Calif.--(BUSINESS WIRE)--Cognita Imaging, Inc. (Cognita), a wholly owned subsidiary of Mosaic Clinical Technologies, Inc. (Mosaic), has received a $1.29 million research contract from the U.S. Food and Drug Administration (FDA) to test a new way of evaluat

Sep 16, 2026

Press release

Cumulus Neuroscience Presents Data at the ISCTM 2026 Autumn Conference

Sep 16, 2026

Press release

Spectral AI Showcases DeepView® System for Burn Indication and KOL Research at Southern Regional Burn Conference

DALLAS, Sept. 16, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today reflected on its successful participation at the Southern Regional Burn Conference (SRBC), held September 10-12, 2026 in Williamsburg, Virginia. The Company’s DeepView® System for Burn Indication was on display for attending burn care clinician

Sep 16, 2026

Press release

Linearis Labs Selected for Two Projects Under Terry Fox Research Institute's Digital Health Innovation Fund

QUÉBEC CITY, Sept. 16, 2026 /PRNewswire/ -- Linearis Labs has been selected to receive funding in two of the 14 pan-Canadian project teams announced today by the Terry Fox Research Institute (TFRI) under its Digital Health Innovation Fund, a program led by TFRI's Digital Health & Discovery Platform (DHDP). The 14 funded projects represent a combined investment of $40.9M and bring together 55 partners across Canada to advance AI-driven health data sharing for precision medicine.In its announc

Sep 16, 2026

Press release

Diagnostic Imaging Market to Reach US$ 33.2 Bn by 2031, Growing at 4.6% CAGR: New Report by Wissen Research

Rising Demand for Early Disease Detection and AI-Enabled Imaging Drives Steady Market Expansion Through 2031SHERIDAN, Wyo., Sept. 16, 2026 /PRNewswire/ -- The global diagnostic imaging market is projected to grow from USD 26.5 billion in 2026 to USD 33.2 billion by 2031, registering a CAGR of 4.6% during the forecast period (2026–2031), according to a new study by Wissen Research.Growth is being driven by rising chronic disease prevalence, an expanding geriatric population, and increasing demand

Sep 16, 2026

Press release

PRC Pairs Workforce Wellbeing Measurement With Frontline Workshops in AP3-Exclusive Package

PRC named a preferred employee experience survey and solutions provider within the ASHHRA Preferred Partner Program, managed in collaboration with LocktonOMAHA, Neb., Sept. 16, 2026 /PRNewswire/ -- Professional Research Consultants (PRC), a national healthcare experience improvement company, today announced an Employee Wellbeing Package that pairs healthcare-calibrated workforce measurement with facilitated workshops, available exclusively to hospitals and health systems participating in the ASH

Sep 16, 2026

Press release

Medisights Pioneers New Standard: AI Agents Capture Unprecedented Near Real-Time Market Intelligence in Complex Diseases Like Multiple Myeloma

NEW YORK, Sept. 16, 2026 /PRNewswire/ -- Medisights, the AI-native platform for life sciences, today announced the successful completion of a landmark study demonstrating that purpose-built Artificial Intelligence (AI) agents can seamlessly navigate the intricate, rapidly evolving landscape of Multiple Myeloma to capture actionable market intelligence at scale. By successfully training AI to track this highly complicated disease state, Medisights has pioneered a new methodology for unlocking phy

A tissue sample on a microscope slide in a dimly lit lab

Sep 16, 2026

DataMEDS AI Jumps as Helomics Acquisition Expands Its Push Into Cancer Diagnostics

DataMEDS AI has seen a remarkable surge in its stock price, rising by 242.4% following a significant acquisition in the cancer diagnostics sector.The primary driver behind this notable increase is the announcement of DataMEDS' acquisition of Helomics, a company specializing in AI-driven cancer diagnostics and precision oncology. This strategic move, completed on September 15, 2026, not only brings a CLIA/CAP-certified laboratory under DataMEDS' umbrella but also marks a pivotal expansion beyond

Back to start
Previous
Page 6 of 84
Next

Daily news on AI, software, and digital tools for pharma, biotech, CROs, and life sciences research labs.

Platform

Legal